Subcardiac threshold vagal nerve stimulation

Details Subcardiac threshold vagal nerve stimulation Subcardiac threshold vagal nerve stimulation

2011-01-11

2011-01-11

Layno, Carl H (Department: 3766)

Surgery: light, thermal, and electrical application

Light, thermal, and electrical application

Electrical therapeutic systems

Reexamination Certificate

active

07869869

ABSTRACT:
In one embodiment, an implantable stimulation apparatus includes a vagal nerve stimulator configured to generate electrical pulses below a cardiac threshold of a heart, and an electrode coupled to the vagal nerve stimulator which is configured to transmit the electrical pulses below the cardiac threshold, to a vagal nerve so as to inhibit injury resulting from an ischemia and/or reduce injury resulting from an ischemia. In another embodiment, an implantable stimulation apparatus includes a vagal nerve stimulator configured to generate electrical pulses below a cardiac threshold, and includes an electrode, which is coupled to the vagal nerve stimulator and configured to transmit electrical pulses to a vagal nerve so as to reduce a defibrillation threshold of the heart.

REFERENCES:
patent: 3774618 (1973-11-01), Avery
patent: 4860769 (1989-08-01), Fogarty et al.
patent: 4934368 (1990-06-01), Lynch
patent: 5170802 (1992-12-01), Mehra
patent: 5224491 (1993-07-01), Mehra
patent: 5231988 (1993-08-01), Wernicke et al.
patent: 5251634 (1993-10-01), Weinberg
patent: 5320643 (1994-06-01), Roline
patent: 5330507 (1994-07-01), Schwartz
patent: 5387233 (1995-02-01), Alferness et al.
patent: 5411546 (1995-05-01), Bowald et al.
patent: 5441521 (1995-08-01), Hedberg
patent: 5476498 (1995-12-01), Ayers
patent: 5578061 (1996-11-01), Stroetmann et al.
patent: 5658318 (1997-08-01), Stroetmann et al.
patent: 5690681 (1997-11-01), Geddes
patent: 5916239 (1999-06-01), Geddes
patent: 5978705 (1999-11-01), KenKnight et al.
patent: 6129750 (2000-10-01), Tockman et al.
patent: 6134470 (2000-10-01), Hartlaub
patent: 6157862 (2000-12-01), Brownlee
patent: 6292695 (2001-09-01), Webster, Jr. et al.
patent: 6341236 (2002-01-01), Osorio et al.
patent: 6349233 (2002-02-01), Adams
patent: 6473644 (2002-10-01), Terry
patent: 6564096 (2003-05-01), Mest
patent: 6587727 (2003-07-01), Osorio
patent: 6615081 (2003-09-01), Boveja
patent: 6628987 (2003-09-01), Hill
patent: 6671556 (2003-12-01), Osorio
patent: 6972016 (2005-12-01), Hill et al.
patent: 7031777 (2006-04-01), Hine et al.
patent: 7072720 (2006-07-01), Puskas
patent: 7321793 (2008-01-01), Ben Ezra
patent: 7734355 (2010-06-01), Cohen et al.
patent: 2002/0120304 (2002-08-01), Mest
patent: 2002/0123771 (2002-09-01), Ideker et al.
patent: 2003/0078623 (2003-04-01), Weinberg
patent: 2003/0181951 (2003-09-01), Cates
patent: 2003/0229380 (2003-12-01), Adams et al.
patent: 2004/0019364 (2004-01-01), Kieval
patent: 2004/0044379 (2004-03-01), Holsheimer
patent: 2004/0172075 (2004-09-01), Shafer et al.
patent: 2005/0065553 (2005-03-01), Ben Ezra
patent: 2005/0143787 (2005-06-01), Boveja
patent: 2005/0149131 (2005-07-01), Libbus
patent: 2006/0173493 (2006-08-01), Armstrong et al.
patent: 2006/0178703 (2006-08-01), Huston
patent: 0566652 (1994-06-01), None
patent: 0566652 (1997-11-01), None
patent: 1304135 (2003-04-01), None
Murakawa et al. “Effect of Cervical Vagal Nerve Stimulation on Defibrillation Energy.” Japanese Heart Journal. vol. 44 (2003) No. 1 pp. 91-100.
Non-Final Office Action mailed May 18, 2007: Related U.S. Appl. No. 11/120,345.
Final Office Action mailed Nov. 28, 2007: Related U.S. Appl. No. 11/120,345.
Non-Final Office Action mailed May 9, 2008: Related U.S. Appl. No. 11/120,345.
Non-Final Office Action mailed May 28, 2008: Related U.S. Appl. No. 11/283,229.
Non-Final Office Action mailed Oct. 15, 2008: Related U.S. Appl. No. 11/120,345.
Non-Final Office Action mailed Feb. 26, 2009: Related U.S. Appl. No. 11/120,345.
Non-Final Office Action mailed Oct. 23, 2008: Related U.S. Appl. No. 11/539,326.
Final Office Action mailed Apr. 7, 2009: Related U.S. Appl. No. 11/539,326.
Final Office Action mailed Dec. 16, 2008: Related U.S. Appl. No. 11/120,345.
Non-Final Office Action mailed Mar. 6, 2009: Related U.S. Appl. No. 11/120,345.
Final Office Action mailed Mar. 18, 2009: Related U.S. Appl. No. 11/283,229.
Borovikova et al. “Vagus Nerve Stimulation Attenuates the Systemic Inflammatory Response to Endotoxin” Nature, vol. 405, May 2000.
Borovikova et al. “Role of the Efferent Vagus Nerve Signaling in the Regulation of the Innate Immune Response to LPS” Shock, vol. 13, 2000.
Blum et al “Role of Cytokines in Heart Failure” American Heart Journal, Feb. 1998.
Final Office Action mailed Sep. 3, 2009: Related U.S. Appl. No. 11/330,885.
Non-Final Office Action mailed Jan. 12, 2010: Related U.S. Appl. No. 11/330,885.
Advisory Action mailed Nov. 13, 2009: Related U.S. Appl. No. 11/330,885.
Notice of Allowance mailed Aug. 26, 2009: Related U.S. Appl. No. 11/120,345.
Non-Final Office Action mailed May 28, 2008: Related U.S. Appl. No. 11/283,229.
Final Office Action mailed Mar. 18, 2009: Related U.S. Appl. No. 11/283,229.
Non-Final Office Action mailed Aug. 20, 2009: Related U.S. Appl. No. 11/283,229.
Final Office Action mailed Feb. 25, 2010: Related U.S. Appl. No. 11/283,229.

Affiliated with

Also associated with

Rating

Subcardiac threshold vagal nerve stimulation does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Subcardiac threshold vagal nerve stimulation, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Subcardiac threshold vagal nerve stimulation will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2638293